We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Hotel Yiannaki and Issue of Equity

30 Aug 2016 08:32

RNS Number : 3955I
Craven House Capital PLC
30 August 2016
 

30 August 2016

 

Craven House Capital Plc

("Craven House" or the "Company")

 

$2,500,000 Convertible Loan to Hotel Yiannaki, Mykonos and Issue of Equity

 

The Company today announces that it has provided a $2,500,000 convertible loan (the "Loan") to Xenod Tour Oikod Epeix Afon Daktylidi AE ("Xenod"), a Greek holding company whose sole asset is the Hotel Yiannaki; a 45 room, four-star hotel, located on the Greek Island of Mykonos. The loan has a term of five years and, upon maturity, is convertible for up to 30% of the equity of Xenod.

 

The Loan has been provided utilising the proceeds of a simultaneous share subscription by Xenod, for 205,423 new Ordinary Shares in the Company priced at $12.17, amounting to an aggregate subscription of $2,500,000. Xenod will utilise the proceeds of the Loan to strengthen its balance sheet and provide capital to undertake expansion of the Hotel Yiannaki, which they believe will enhance the profitability of its operations.

 

Application has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on 2 September 2016. The shares will rank pari passu with the existing issued ordinary shares.

 

Mark Pajak, Acting Chairman, commented:

 

"We are delighted to announce this investment in what is an outstanding, profitable hotel operation on the popular Island of Mykonos."

 

Following the issue of the new Ordinary Shares, the Company's total issued share capital will consist of 2,044,362 ordinary shares with each share carrying the right to one vote. The Company has no ordinary shares held in treasury. The total of 2,044,362 ordinary shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 020 7002 1027

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.sparkadvisorypartners.com

Tel: 020 3368 3550

 

 

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

 

Notes to Editors:

 

About the Hotel Yiannaki:

www.yiannali.gr

 

"Painted in the traditional Greek colors of blue and white, nestling on a hill overlooking the bay of Ornos, Hotel Yiannaki is the perfect setting for your time on the Mykonos (Myconos) Island. It is well situated for a day on the beach or a night in Mykonos town. Newly refurbished with excellent facilities complementing the ever excellent service Hotel Yiannaki is not only a 4 star hotel in Mykonos, but a hotel that welcomes you like a member of family.

 

The Yiannaki Hotel is located in the settlement of Ornos, in a beautiful bay area, on the western side of Mykonos Island. The hotel is situated just 200 meters from the beach and offers a beautiful view from its room balconies."

 

About Craven House Capital

 

Craven House Capital is a frontier and emerging market focused merchant bank seeking value oriented long term investments. Craven House invests in all segments of the capital structure in partnership with local entrepreneurs and the local business community. Craven House provides long term patient capital and is often involved in restructuring, expansion and turn around investments in crisis and transitioning economies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUUWRUPQUMU
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.